Rallybio Corp (RLYB) Historical Stock Prices
Rallybio Corp (RLYB) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RLYB
CIK: 1739410
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerChristopher Smith
Audit LocationHartford, Connecticut, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| EFFECT | 2026-10-15 | — | EFFECT Filing | 9999999995-26-003252 | View SEC Doc Filr Page |
| 424B3 | 2026-10-15 | — | 424B3 | 0001193125-26-422924 | View SEC Doc Filr Page |
| S-4/A | 2026-10-14 | — | S-4/A NO. 4 | 0001193125-26-421809 | View SEC Doc Filr Page |
| 4 | 2026-10-14 | 2026-10-12 | 4 | 0001193125-26-421747 | View SEC Doc Filr Page |
| 4 | 2026-10-13 | 2026-10-09 | 4 | 0001193125-26-420562 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | 4 | 0001193125-26-418051 | View SEC Doc Filr Page |
| S-4/A | 2026-10-05 | — | S-4/A NO. 3 | 0001193125-26-412774 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-29 | 4 | 0001193125-26-410885 | View SEC Doc Filr Page |
| 4 | 2026-09-28 | 2026-09-24 | 4 | 0001193125-26-405753 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | 4 | 0001193125-26-395755 | View SEC Doc Filr Page |
| S-4/A | 2026-09-16 | — | S-4/A NO. 2 | 0001193125-26-392246 | View SEC Doc Filr Page |
| 8-K | 2026-09-09 | 2026-09-08 | 8-K | 0001193125-26-386511 | View SEC Doc Filr Page |
| S-4/A | 2026-08-26 | — | S-4/A | 0001193125-26-368568 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097296 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003694 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003435 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-002189 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001628280-26-053880 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-04 | — | SCHEDULE 13G/A Filing | 0001390202-26-000012 | View SEC Doc Filr Page |
| S-4 | 2026-07-15 | — | S-4 | 0001193125-26-304966 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-06 | 4 | 0001193125-26-300913 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-05 | — | SCHEDULE 13G Filing | 0001104659-26-071013 | View SEC Doc Filr Page |
| 425 | 2026-06-01 | — | 425 | 0001193125-26-249801 | View SEC Doc Filr Page |
| 8-K | 2026-06-01 | 2026-05-31 | 8-K | 0001193125-26-249790 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-05-18 | OWNERSHIP DOCUMENT | 0001104659-26-064729 | View SEC Doc Filr Page |